Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer.
Saved in:
| Title: | Circulating NKp46+ Natural Killer cells have a potential regulatory property and predict distinct survival in Non-Small Cell Lung Cancer. |
|---|---|
| Authors: | Picard E; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Godet Y; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Laheurte C; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France.; University Hospital of Besançon, INSERM CIC-1431 Clinical Investigation Center in Biotherapies, Besançon, France., Dosset M; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Galaine J; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Beziaud L; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Loyon R; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Boullerot L; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Lauret Marie Joseph E; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Spehner L; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Jacquin M; University Hospital of Besançon, INSERM CIC-1431 Clinical Investigation Center in Biotherapies, Besançon, France., Eberst G; University Hospital of Besançon, Department of Pneumology, Besançon, France., Gaugler B; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France., Le Pimpec-Barthes F; Service de Chirurgie Thoracique, AP-HP, Hôpital Européen Georges Pompidou, Paris, France., Fabre E; Service d'Oncologie Médicale, AP-HP, Hôpital Européen Georges Pompidou, Paris, France., Westeel V; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France.; University Hospital of Besançon, Department of Pneumology, Besançon, France., Caignard A; INSERM, UMR1160, Institut Universitaire d'hématologie, Paris, France., Borg C; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France.; University Hospital of Besançon, Department of Medical Oncology, Besançon, France., Adotévi O; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, LabEx LipSTIC, Besançon, France.; University Hospital of Besançon, Department of Medical Oncology, Besançon, France. |
| Source: | Oncoimmunology [Oncoimmunology] 2018 Oct 19; Vol. 8 (2), pp. e1527498. Date of Electronic Publication: 2018 Oct 19 (Print Publication: 2019). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2162-4011 |
|---|---|
| DOI: | 10.1080/2162402X.2018.1527498 |
